Guest guest Posted September 6, 2005 Report Share Posted September 6, 2005 Japanese Diabetes Combo Gets Nod TUESDAY, Aug. 30 (HealthDay News) -- Takeda Pharmaceutical Co. of Tokyo has received U.S. Food and Drug Administration approval for its new diabetes drug and will begin selling it in October, the company said Tuesday. The new product, Actoplus Met, is a single tablet that combines two existing diabetes drugs, Actos and Metformin, and will be sold in the United States by Takeda Pharmaceuticals North America Inc., the Associated Press reported. Actos is a drug used to improve insulin resistance, and Metformin is used to control the level of glucose produced by the liver. The new drug will mean that type 2 diabetes patients no longer need to take two tablets for the same treatment, said Matsutaka Matsumoto, of Takeda Pharmaceutical Co. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.